References
- Bombardieri M, McInnes IB, Pitzalis C (2007). Interleukin-18 as a potential therapeutic target in chronic autoimmune/inflammatory conditions. Expert Opin Biol Th, 7, 31-40. https://doi.org/10.1517/14712598.7.1.31
- Chan AT, Teo PM, Johnson PJ (2002). Nasopharyngeal carcinoma. Ann Oncol, 13, 1007-15. https://doi.org/10.1093/annonc/mdf179
- Cochran WG (1968). The effectiveness of adjustment by subclassification in removing bias in observational studies. Biometrics, 24, 295-313. https://doi.org/10.2307/2528036
- DeSantis C, Naishadham D, Jemal A (2013). Cancer statistics for African Americans, 2013. CA-Cancer J Clin, 63,151-66. https://doi.org/10.3322/caac.21173
- Dinarello CA, Novick D, Kim S, Kaplanski G (2013). Interleukin-18 and IL-18 Binding Protein. Front Immunol, 4, 289.
- Du B, Zhao J, Wei Y (2012). Interleukin-18 gene genetic polymorphisms and risk Of nasopharyngeal carcinoma in Han population from Sichuan China. Med J West China, 25, 1683-6.
- Egger M, Smith G, Schneider M, Minder C. (1997). Bias in meta-analysis detected by a simple, graphical test. BMJ, 315, 629-34. https://doi.org/10.1136/bmj.315.7109.629
- Farhat K, Hassen E, Bouzgarrou N, et al (2008). Functional IL-18 promoter gene polymorphisms in Tunisian nasopharyngeal carcinoma patients. Cytokine, 43, 132-7. https://doi.org/10.1016/j.cyto.2008.05.004
- Fariasa TD, Canto LM, Medeiros MD, et al (2013). Lack of association between interleukin-18 polymorphisms and rheumatoid arthritis. Rev Bras Reumatol, 53, 199-205. https://doi.org/10.1590/S0482-50042013000200007
- Jemal A, Bray F, Center MM, et al (2011). Global Cancer Statistics. CA-Cancer J Clin, 61, 69-90. https://doi.org/10.3322/caac.20107
- Ji J, Lee W (2013). Interleukin-18 gene polymorphisms and rheumatoid arthritis: A meta-analysis. Gene, 523, 27-32. https://doi.org/10.1016/j.gene.2013.03.132
- Ma Y, Zhang B, Tang R, et al (2012). Interleukin-18 promoter polymorphism and asthma risk: a meta-analysis. Mol Biol Rep, 39, 1371-6. https://doi.org/10.1007/s11033-011-0871-6
- Mantel N, Haensze W (1959). Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer I, 22, 719-48.
- Mi Y, Yu Q, Yu M, et al (2011). Review and pooled analysis of studies on -607 (C/A) and -137 (G/C) polymorphisms in IL-18 and cancer risk. Med Oncol, 28, 1107-15. https://doi.org/10.1007/s12032-010-9569-1
- Nong L, Luo B, Zhang L, Nong H (2009). Interleukin-18 gene promoter polymorphism and the risk of nasopharyngeal carcinoma in a Chinese population. DNA Cell Biol, 28, 507-13. https://doi.org/10.1089/dna.2009.0912
- Pan G, Luo B, Teng Y, Liang L (2013). Research on interleukin-18 gene promotoe polymorphisms and genetic susceptibility of nasopharngeal carcinoma. Lab Med, 28, 457-61.
- Pratesi C, Bortolin MT, Bidoli E, et al (2006). Interleukin-10 and interleukin-18 promoter polymorphisms in an Italian cohort of patients with undifferentiated carcinoma of nasopharyngeal type. Cancer Immunol Immun, 55,23-30. https://doi.org/10.1007/s00262-005-0688-z
- Song G, Bae S, Kim J, Lee Y (2013). Interleukin-4, interleukin-4 receptor, and interleukin-18 polymorphisms and rheumatoid arthritis: a meta-analysis. Immunol Invest, 42, 455-69. https://doi.org/10.3109/08820139.2013.804084
- Song G, Choi S, Ji J, Lee Y (2013). Association between interleukin-18 polymorphisms and systemic lupus erythematosus: a meta-analysis. Mol Biol Rep, 40, 2581-7. https://doi.org/10.1007/s11033-012-2344-y
- Srivastava S, Salim N, and Robertson MJ (2010). Interleukin-18: Biology and Role in the Immunotherapy of Cancer. Curr Med Chem, 17, 3353-7. https://doi.org/10.2174/092986710793176348
- Stuck AE, Rubenstein LZ, and Wieland D (1998). Bias in meta-analysis detected by a simple, graphical test. Asymmetry detected in funnel plot was probably due to true heterogeneity. BMJ, 316, 469 https://doi.org/10.1136/bmj.316.7129.469
- Thakkinstian A, McElduff P, Este C, et al (2005). A method for meta-analysis of molecular association studies. Stat Med, 24, 1291-306. https://doi.org/10.1002/sim.2010
- Wang M, Zhu X, Wang L, Lin Y (2013). The -607C/A Polymorphisms in Interleukin-18 Gene Promoter Contributes to Cancer Risk: Evidence from A Meta-Analysis of 22 Case-Control Studies. Plos One, 8, e76915. https://doi.org/10.1371/journal.pone.0076915
- Yang X, Qiu M, Hu J, et al (2013). Association of interleukin-18 gene promoter -607 C>A and -137G>C polymorphisms with cancer risk: a meta-analysis of 26 studies. Plos One, 8, e73671. https://doi.org/10.1371/journal.pone.0073671
- Yang Y, Chang T, Chen T, et al (2013). Genetic variants in interleukin-18 gene and risk for cervical squamous cell carcinoma. Hum Immunol, 74, 882-7. https://doi.org/10.1016/j.humimm.2013.04.001
Cited by
- The AURKA Gene rs2273535 Polymorphism Contributes to Breast Carcinoma Risk - Meta-analysis of Eleven Studies vol.15, pp.16, 2014, https://doi.org/10.7314/APJCP.2014.15.16.6709
- Five miRNAs as Novel Diagnostic Biomarker Candidates for Primary Nasopharyngeal Carcinoma vol.15, pp.18, 2014, https://doi.org/10.7314/APJCP.2014.15.18.7575
- Functional polymorphisms of interleukin-18 gene and risk of breast cancer in a Brazilian population vol.84, pp.2, 2014, https://doi.org/10.1111/tan.12367
- Semi-Quantitative Exposure Assessment of Occupational Exposure to Wood Dust and Nasopharyngeal Cancer Risk vol.16, pp.10, 2015, https://doi.org/10.7314/APJCP.2015.16.10.4339
- Interleukin-18 in Health and Disease vol.20, pp.3, 2019, https://doi.org/10.3390/ijms20030649